Prosecution Insights
Last updated: May 04, 2026
Application No. 17/981,563

HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL

Non-Final OA §102§112
Filed
Nov 07, 2022
Priority
Jun 30, 2022 — CN 202210772873.9
Examiner
NGUYEN, VU ANH
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Wuhan Tianma Microelectronics Co., Ltd.
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
1250 granted / 1502 resolved
+18.2% vs TC avg
Strong +16% interview lift
Without
With
+15.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
27 currently pending
Career history
1529
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
37.8%
-2.2% vs TC avg
§102
29.2%
-10.8% vs TC avg
§112
27.3%
-12.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1502 resolved cases

Office Action

§102 §112
DETAILED ACTION Drawings The drawings are objected to under 37 CFR 1.84(u) because “[w]here only a single view is used in an application to illustrate the claimed invention, it must not be numbered and the abbreviation "FIG." must not appear.” Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-9 and 11-12 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. It is unclear as to what is meant by the phrase “substituted substituents”. Perhaps it should be changed to “substituents”. In addition, the chemical structure P012 in claim 10 is missing a bond. Other claims are indefinite by dependency. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-7 and 11-12 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by WO 2021/261851 A1 to Lee et al. Regarding claim 1, Lee et al. discloses an OLED comprising an anode, a plurality of organic material layers, a cathode, and a capping layer, in that order, wherein the capping layer comprises a compound exemplified by PNG media_image1.png 228 174 media_image1.png Greyscale and PNG media_image2.png 230 142 media_image2.png Greyscale . These compounds are representative of the claimed compound and claim 1 is therefore anticipated. See MPEP § 2131.02(II). Claims 2-7 and 11-12 are also anticipated. Allowable Subject Matter Claim 10 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claims 8-9 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The claimed compounds are not disclosed or suggested by the prior art of record. Other Prior Art of Record The compound of claim 1 and the device of claims 11-12 are disclosed by WO 2021/020799 A1 to Hee et al. (see compound 1-85 on page 18). An example of the compound of claim 1 is disclosed by CN-111635410-A to Du et al. (see compound 316 on page 14), CN-108658980-A to Zhou et al. (see compound HT91 on page 6) and KR 2021/0133331-A. KR 2021/0142561-A discloses a similar compound but has two amino centers. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to VU ANH NGUYEN whose telephone number is (571)270-5454. The examiner can normally be reached M-F 8:00 AM-5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, ROBERT JONES can be reached at (571) 270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /VU A NGUYEN/Primary Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Nov 07, 2022
Application Filed
Feb 03, 2026
Non-Final Rejection — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12615962
ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF
3y 7m to grant Granted Apr 28, 2026
Patent 12606563
ORGANIC LIGHT-EMITTING DEVICE
4y 2m to grant Granted Apr 21, 2026
Patent 12610737
COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF
10m to grant Granted Apr 21, 2026
Patent 12604662
LIGHT-EMITTING DEVICE AND LIGHT-EMITTING APPARATUS
3y 9m to grant Granted Apr 14, 2026
Patent 12600885
COMPOSITION INCLUDING MONOMER WITH A CARBOXYLIC ACID GROUP, MONOMER WITH A HYDROXYL GROUP, AN ALKYL MONOMER, AND CROSSLINKER AND RELATED ARTICLE AND METHOD
2y 2m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
99%
With Interview (+15.9%)
2y 5m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1502 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month